Recombinant Mouse CXCL13/BLC/BCA-1 Protein

Carrier Free

Catalog # Availability Size / Price Qty
470-BC-025/CF

With Carrier

Catalog # Availability Size / Price Qty
470-BC-025
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (19)
FAQs
Reviews

Recombinant Mouse CXCL13/BLC/BCA-1 Protein Summary

Product Specifications

Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to chemoattract BaF3 mouse pro‑B cells transfected with human CXCR5. The ED50 for this effect is 0.5‑2 µg/mL.
Source
E. coli-derived mouse CXCL13/BLC/BCA-1 protein
Ile22-Ala109
Accession #
N-terminal Sequence
Analysis
Ile22
Predicted Molecular Mass
9.8 kDa

Product Datasheets

You must select a language.

x

470-BC (with carrier)

You must select a language.

x

470-BC/CF (carrier free)

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

470-BC

Formulation Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Reconstitution Reconstitute at 25 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

470-BC/CF

Formulation Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CXCL13/BLC/BCA-1

CXCL13, also known as B-lymphocyte chemoattractant (BLC), is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Mouse BCA-1 cDNA encodes a precursor protein of 109 amino acid residues with a putative leader sequence of 21 residues. Mature mouse BCA-1 shares 64% amino acid sequence similarity with the human protein and 23 - 34% amino acid sequence identity with other known CXC chemokines. Recombinant or chemically synthesized BCA-1 is a potent chemoattractant for B lymphocytes but not T lymphocytes, monocytes or neutrophils. BLR1, a G protein-coupled receptor originally isolated from Burkitt’s lymphoma cells, has now been shown to be the specific receptor for BCA-1. Among cells of the hematopoietic lineages, the expression of BLR1, now designated CXCR5, is restricted to B lymphocytes and a subpopulation of T helper memory cells. Mice lacking BLR1 have been shown to lack inguinal lymph nodes. These mice were also found to have impaired development of Peyer’s patches and defective formation of primary follicles and germinal centers in the spleen as a result of the inability of B lymphocytes to migrate into B cell areas.

References
  1. Gunn, M.D. et al. (1998) Nature, 391:799.
  2. Legler, D.F. et al. (1998) J. Exp. Med. 187:655.
  3. Forster, R. et al. (1996) Cell 87:1037.
Entrez Gene IDs
10563 (Human); 55985 (Mouse)
Alternate Names
ANGIE; ANGIE2; B cell-attracting chemokine 1; B lymphocyte chemoattractant; BCA1; BCA-1; BCA1B-cell chemoattractant; BCA-1CXC chemokine BLC; B-cell-homing chemokine (ligand for Burkitt's lymphoma receptor-1); BLC; BLCSmall-inducible cytokine B13; BLR1L; B-lymphocyte chemoattractant; chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant); chemokine (C-X-C motif) ligand 13; C-X-C motif chemokine 13; CXCL13; SCYB13; SCYB13B-cell-attracting chemokine 1; small inducible cytokine B subfamily (Cys-X-Cys motif), member 13 (B-cellchemoattractant)

Citations for Recombinant Mouse CXCL13/BLC/BCA-1 Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

19 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-?B activation and pro-inflammatory cytokine production in spinal cord dorsal horn
    Authors: Wang, J;Yin, C;Pan, Y;Yang, Y;Li, W;Ni, H;Liu, B;Nie, H;Xu, R;Wei, H;Zhang, Y;Li, Y;Hu, Q;Tai, Y;Shao, X;Fang, J;Liu, B;
    Journal of neuroinflammation
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  2. CXCL13-producing CD4+ T cells accumulate in early phase of tertiary lymphoid structures in ovarian cancer
    Authors: M Ukita, J Hamanishi, H Yoshitomi, K Yamanoi, S Takamatsu, A Ueda, H Suzuki, Y Hosoe, Y Furutake, M Taki, K Abiko, K Yamaguchi, H Nakai, T Baba, N Matsumura, A Yoshizawa, H Ueno, M Mandai
    JCI Insight, 2022-06-22;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  3. Kindlin-3 maintains marginal zone B cells but confines follicular B cell activation and differentiation
    Authors: A Härzschel, L Li, PW Krenn, E Szenes-Nag, G Andrieux, E Bayer, D Pfeifer, L Polcik, U Denk, JP Höpner, E Karabatak, DJ Danner, S Tangermann, L Kenner, H Jumaa, R Greil, M Börries, R Ruppert, PC Maity, TN Hartmann
    Journal of leukocyte biology, 2021-12-10;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  4. Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis
    Authors: A Ardain, R Domingo-Go, S Das, SW Kazer, NC Howard, A Singh, M Ahmed, S Nhamoyebon, J Rangel-Mor, P Ogongo, L Lu, D Ramsuran, M de la Luz, T K Ulland, M Darby, E Park, F Karim, L Melocchi, R Madansein, KJ Dullabh, M Dunlap, N Marin-Agud, T Ebihara, T Ndung'u, D Kaushal, AS Pym, JK Kolls, A Steyn, J Zúñiga, W Horsnell, WM Yokoyama, AK Shalek, HN Kløverpris, M Colonna, A Leslie, SA Khader
    Nature, 2019-06-05;570(7762):528-532.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  5. Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1
    Authors: R Mashud, A Nomachi, A Hayakawa, K Kubouchi, S Danno, T Hirata, K Matsuo, T Nakayama, R Satoh, R Sugiura, M Abe, K Sakimura, S Wakana, H Ohsaki, S Kamoshida, H Mukai
    Sci Rep, 2017-08-09;7(1):7663.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  6. The Small Rho GTPase TC10 Modulates B Cell Immune Responses
    Authors: M Burbage, SJ Keppler, B Montaner, PK Mattila, FD Batista
    J. Immunol., 2017-07-26;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  7. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway
    Authors: R Garg, JM Blando, CJ Perez, MC Abba, F Benavides, MG Kazanietz
    Cell Rep, 2017-04-11;19(2):375-388.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  8. Efficient Plasma Cell Differentiation and Trafficking Require Cxcr4 Desensitization
    Cell Rep, 2016-09-27;17(1):193-205.
    Species: Mouse
    Sample Types:
    Applications: Bioassay
  9. IL-10+ Innate-like B Cells Are Part of the Skin Immune System and Require ?4?1 Integrin To Migrate between the Peritoneum and Inflamed Skin
    Authors: SA Geherin, D Gómez, RA Glabman, G Ruthel, A Hamann, GF Debes
    J. Immunol, 2016-02-05;196(6):2514-25.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFkappaB and ERK.
    Authors: Badr G, Sayed A, Abdel-Maksoud M, Mohamed A, El-Amir A, Abdel-Ghaffar F, Al-Quraishy S, Mahmoud M
    PLoS ONE, 2015-04-24;10(4):e0125340.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  11. An essential role for RGS protein/Galphai2 interactions in B lymphocyte-directed cell migration and trafficking.
    Authors: Hwang I, Park C, Harrison K, Boularan C, Gales C, Kehrl J
    J Immunol, 2015-01-23;194(5):2128-39.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  12. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.
    Authors: Graham K, Zhang J, Lewen S, Burke T, Dang T, Zoudilova M, Sobel R, Butcher E, Zabel B
    PLoS ONE, 2014-12-01;9(12):e112925.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  13. Control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors.
    Authors: Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K
    J Exp Med, 2014-11-24;211(13):2583-98.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  14. Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers.
    Authors: Moriyama S, Takahashi N, Green J, Hori S, Kubo M, Cyster J, Okada T
    J Exp Med, 2014-06-09;211(7):1297-305.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  15. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling.
    Authors: Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, Hobeika E, Levit-Zerdoun E, Tenbrock K, Reth M, Bernhagen J, El Bounkari O
    J Immunol, 2014-04-23;192(11):5273-84.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  16. Follicular regulatory T cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression.
    Authors: Vaeth M, Muller G, Stauss D, Dietz L, Klein-Hessling S, Serfling E, Lipp M, Berberich I, Berberich-Siebelt F
    J Exp Med, 2014-03-03;211(3):545-61.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  17. Rgs13 constrains early B cell responses and limits germinal center sizes.
    Authors: Hwang I, Hwang K, Park C, Harrison K, Kehrl J
    PLoS ONE, 2013-03-22;8(3):e60139.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  18. Factors expressed by murine embryonic pancreatic mesenchyme enhance generation of insulin-producing cells from hESCs.
    Authors: Guo T, Landsman L, Li N, Hebrok M
    Diabetes, 2013-01-10;62(5):1581-92.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: Bioassay
  19. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization.
    Authors: Ippagunta SK, Malireddi RK, Shaw PJ
    Nat. Immunol., 2011-09-04;12(10):1010-6.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Mouse CXCL13/BLC/BCA-1 Protein

There are currently no reviews for this product. Be the first to review Recombinant Mouse CXCL13/BLC/BCA-1 Protein and earn rewards!

Have you used Recombinant Mouse CXCL13/BLC/BCA-1 Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review